Hala Tfayli1, So Jung Lee, Fida Bacha, Silva Arslanian. 1. Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA 15224, USA.
Abstract
BACKGROUND: In adults 1-h plasma glucose concentration cut-point of 155 mg/dL (8.6 mmol/L) during the oral glucose tolerance test (OGTT) is a strong predictor of future diabetes risk. OBJECTIVE: We tested the hypothesis that a 1-h glucose concentration ≥155 mg/dL is associated with lower β-cell function in overweight/obese youth. RESEARCH DESIGN AND METHODS: One hundred and thirteen diabetes free overweight/obese youth aged 10-20 yr, underwent evaluation of β-cell function during a 2 h hyperglycemic clamp ∼225 mg/dL (12.5 mmol/L), and insulin sensitivity during a 3 h hyperinsulinemic-euglycemic clamp, and a standard 2 h OGTT. Body composition and abdominal adiposity were determined by DEXA and CT scan. The disposition index (DI) was calculated as the product of first-phase insulin secretion and insulin sensitivity. Subjects were divided into two categories of 1-h plasma glucose concentration: <155 mg/dL (n=69) and ≥155 mg/dL (n=44). RESULTS: Youth with 1-h glucose ≥155 mg/dL had lower DI than those with 1-h glucose <155 mg/dL (295.1 ± 27.4 vs. 498.6 ± 37.7 mg/kg/min, p<0.001), independent of the glucose tolerance status. In multiple regression models, DI was the strongest contributor to 1-h glucose concentration explaining ∼21% of its variance. CONCLUSIONS: Overweight/obese youth with 1-h glucose ≥155 mg/dL during the oral glucose tolerance test have a significantly lower β-cell function relative to insulin sensitivity even within the normal glucose tolerance range. Such youth may be at higher risk of future diabetes.
BACKGROUND: In adults 1-h plasma glucose concentration cut-point of 155 mg/dL (8.6 mmol/L) during the oral glucose tolerance test (OGTT) is a strong predictor of future diabetes risk. OBJECTIVE: We tested the hypothesis that a 1-h glucose concentration ≥155 mg/dL is associated with lower β-cell function in overweight/obese youth. RESEARCH DESIGN AND METHODS: One hundred and thirteen diabetes free overweight/obese youth aged 10-20 yr, underwent evaluation of β-cell function during a 2 h hyperglycemic clamp ∼225 mg/dL (12.5 mmol/L), and insulin sensitivity during a 3 h hyperinsulinemic-euglycemic clamp, and a standard 2 h OGTT. Body composition and abdominal adiposity were determined by DEXA and CT scan. The disposition index (DI) was calculated as the product of first-phase insulin secretion and insulin sensitivity. Subjects were divided into two categories of 1-h plasma glucose concentration: <155 mg/dL (n=69) and ≥155 mg/dL (n=44). RESULTS: Youth with 1-h glucose ≥155 mg/dL had lower DI than those with 1-h glucose <155 mg/dL (295.1 ± 27.4 vs. 498.6 ± 37.7 mg/kg/min, p<0.001), independent of the glucose tolerance status. In multiple regression models, DI was the strongest contributor to 1-h glucose concentration explaining ∼21% of its variance. CONCLUSIONS: Overweight/obese youth with 1-h glucose ≥155 mg/dL during the oral glucose tolerance test have a significantly lower β-cell function relative to insulin sensitivity even within the normal glucose tolerance range. Such youth may be at higher risk of future diabetes.
Authors: M L Marcovecchio; M Bagordo; E Marisi; T de Giorgis; V Chiavaroli; F Chiarelli; A Mohn Journal: J Endocrinol Invest Date: 2017-03-01 Impact factor: 4.256
Authors: Joon Young Kim; Sara F Michaliszyn; Alexis Nasr; SoJung Lee; Hala Tfayli; Tamara Hannon; Kara S Hughan; Fida Bacha; Silva Arslanian Journal: Diabetes Care Date: 2016-06-12 Impact factor: 19.112
Authors: Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert Journal: Diabetes Res Clin Pract Date: 2020-06-01 Impact factor: 5.602
Authors: Kalie L Tommerdahl; John T Brinton; Tim Vigers; Melanie Cree-Green; Philip S Zeitler; Kristen J Nadeau; Christine L Chan Journal: J Cyst Fibros Date: 2020-09-11 Impact factor: 5.482